Illumina Inc

NASDAQ: ILMN
$131.20
-$3.19 (-2.4%)
Closing Price on September 20, 2024

ILMN Articles

The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short...
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short...
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the period...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Celgene Corporation (NASDAQ: CELG) Maintained Buy with target of $73.00...
The major US stock indexes opened lower this morning following a weekend of elections in Europe. A new Socialist party president in France and a still very cloudy future in Greece have left investors...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday. Annie’s, Inc. (NYSE: BNNY) Started as Overweight at JPMorgan; Started...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. Allison Transmission Holdings, Inc. (NYSE: ALSN) Started as Neutral at...
Earnings season is in full swing and we have many key reports due in the coming week.  24/7 Wall St. has provided some detailed previews for the key earnings reports we expect to show in detail on...
Gasoline dipped below $3.90, based on the AAA assessment of the average price for a gallon of regular nationwide. The price yesterday was $3.891, down from $3.899 the day before and $3.907 a week...
Illumina (NASDAQ: ILMN) shareholders may be in for a rude surprise. Suitor Roche could be close to walking away from a $6.8 billion offer which values the gene research company’s shares at $51....
Biotech is a sector which is often mixed with a hodge-podge of winners and losers based on news flow from analysts and/or key drug developments which often have very little to do with the broad...
Google (NASDAQ: GOOG) splits its stock in a way that will help its founders keep control, and the company also announces strong earnings. (Reuters) China’s GDP reaches a three-year low. (Reuters)...
Apartment vacancy rates reach a 10-year low, according to Reis. (Reuters) Tom Glocer, the departing head of Thomson Reuters (NYSE: TRI), makes $20 million. (Reuters) China’s premier, Wen Jiabao,...
Apple’s (NASDAQ: AAPL) iPad is the number one tablet PC in a new Consumer Reports survey. (Reuters) CEO pay jumps for last year as stock options rise. (Reuters) Avon (NYSE: AVP) turns down a $10...
The heads of the BRIC nations say the pace of IMF-led reforms concerns them. (Reuters) Facebook cuts trading of its stock in the secondary markets. (Reuters) The board of Goldman Sachs (NYSE: GS)...